KALA

Kala Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update

Kala Pharmaceuticals Has Good Short- And Long-Term Prospects

Kala Pharmaceuticals: Eye Treatment Specialist With Much To Prove May Have Just The Product

Kala Pharmaceuticals to Present at Upcoming Investor Conferences in March

Kala Pharmaceuticals, Inc. (KALA) CEO Mark Iwicki on Q4 2020 Results - Earnings Call Transcript

Kala Pharmaceuticals (KALA) Reports Q4 Loss, Lags Revenue Estimates

Kala Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call